美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

INVESCO BIOTECHNOLOGY & GENOME ETF

95.67

+2.302.46%

盤後：95.670.00000.00%16:10 EDT

成交量：1.04萬

成交額：99.11萬

市值：4.15億

市盈率：53.35

高：95.68

開：93.80

低：93.80

收：93.37

52周最高：98.82

52周最低：67.69

股本：434.00萬

流通股本：434.00萬

量比：0.92

換手率：0.24%

股息：1.55

股息率：1.62%

每股收益(TTM):1.79

每股收益(LYR):18.65

淨資產收益率：24.76%

總資產收益率：0.08%

市淨率：1.68

市盈率(LYR):5.13

資料載入中...

總覽公司新聞資訊公告

翰思艾泰-B(03378)：擬與華科前沿交叉研究中心打造新一代AI驅動的創新藥研發範式

數據簡報-過去十年間美國製藥企業和生物技術公司參與的重大交易

每日特惠-併購

美股異動丨Crinetics盤前暴升逾99%，獲福泰製藥斥100億美元溢價超一倍收購

100億美元砸出史上最大收購：福泰製藥(VRTX.US)溢價100%收購Crinetics(CRNX.US)，殺入內分泌賽道

SEC文件披露：特定情況下交易終止，Crinetics Pharmaceuticals或需向福泰製藥支付3.5047億美元解約費

福泰製藥百億收購案引爆市場，Crinetics盤後股價翻倍飆升，終盤收漲101%至84.80美元

生物製藥公司Crinetics盤後升逾100%福泰製藥將以85美元/股收購公司。

Vertex將以100億美元收購Crinetics

Crinetics與福泰製藥交易預計2029年提升後者非GAAP運營收入

Crinetics Pharmaceuticals：融資獲美國銀行與摩根士丹利的45億美元全額承諾過橋貸款支持

福泰製藥就囊性纖維化療法Alyftrek與泛加拿大藥品聯盟簽署意向書

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/PBE/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":95.6698,"timestamp":1789675200000,"preClose":93.3693,"halted":0,"volume":10417,"hourTrading":{"tag":"盘后","latestPrice":95.6698,"preClose":95.6698,"latestTime":"16:10 EDT","volume":9,"amount":860.229,"timestamp":1789675804338,"change":0,"changeRate":0,"amplitude":0.010871},"delay":0,"changeRate":0.02463871957913361,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"盤後交易","change":2.3005,"latestTime":"09-17 18:25:59 EDT","open":93.8,"high":95.68,"low":93.8,"amount":991106,"amplitude":0.020135,"askPrice":104.91,"askSize":100,"bidPrice":86.59,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":93.3693,"sharesOutstanding":3180000,"nav":93.02867,"aum":405605001.2,"dividendRate":0.016201,"bidAskSpread":0.001979,"preHourTrading":{"tag":"盘前","latestPrice":93.3693,"preClose":93.3693,"latestTime":"07:00 EDT","volume":1,"amount":93.3693,"timestamp":1789642840517,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":95.6698,"preClose":95.6698,"latestTime":"16:10 EDT","volume":9,"amount":860.229,"timestamp":1789675804338,"change":0,"changeRate":0,"amplitude":0.010871},"volumeRatio":0.918299,"impliedVol":0.1148,"impliedVolPercentile":0.0359},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.918299,"shares":4340000,"dividePrice":1.5499,"high":95.68,"amplitude":0.020135,"preClose":93.3693,"low":93.8,"week52Low":67.69,"pbRate":"1.68","psRate":"241.87","week52High":98.82,"institutionHeld":0.2552,"latestPrice":95.6698,"eps":1.793292,"divideRate":0.016201,"volume":10417,"delay":0,"ttmEps":1.793292,"open":93.8,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":93.03,"twentyDayClose":98.2643,"sixtyDayClose":85.4379},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649984355","title":"翰思艾泰-B(03378)：擬與華科前沿交叉研究中心打造新一代AI驅動的創新藥研發範式","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984355","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984355?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 18:57","pubTimestamp":1783421872,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B 发布公告，为充分发挥产学研结合的优势，加速生物医药研发创新，公司于近日与华科—澳城大高等研究院前沿交叉研究中心正式签署了《“人工智能药物研发联合实验室”合作共建协议》。双方将依托华科前沿交叉研究中心的AI平台，以及翰思艾泰在创新药研发的丰富经验和对疾病领域的深度认知，围绕抗体发现与分子设计展开深度合作，共同打造新一代AI驱动的创新药研发范式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1535","GSKH","BK4585","03378","BK1173","AGIX","QTOC","WRND","PBE","AIPO","BK1161","BBP","IBB","ARTY","BK4588","GDOC","CHAT","VTHR","SBIO","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649896009","title":"數據簡報-過去十年間美國製藥企業和生物技術公司參與的重大交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2649896009","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649896009?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 18:10","pubTimestamp":1783419013,"startTime":"0","endTime":"0","summary":"数据简报-过去十年间美国制药企业和生物技术公司参与的重大交易在第1段和表格中补充了Vertex交易的相关细节路透7月7日-Vertex制药公司已同意以约100亿美元收购Crinetics制药公司，将其业务范围从血液疾病和疼痛领域扩展至罕见内分泌疾病领域。此举进一步丰富了过去十年间美国制药公司为获取从肿瘤学、神经学到罕见病及肥胖症等领域有前景疗法而进行的一系列备受瞩目的交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T4390TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2324357040.USD","LU0109394709.USD","IE00B2B36J28.USD","SGXZ57979304.SGD","IBB","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2456880835.USD","SG9999001176.USD","IE00B4R5TH58.HKD","BK4139","LU1585245621.USD","LU1674673691.USD","LU0256863811.USD","IE00B19Z3581.USD","SG9999013999.USD","LU1035775433.USD","BBH","LU1093756325.SGD","VRTX","LU1778281490.HKD","IE0002270589.USD","BIB","IE00BJT1NW94.SGD","LU1674673428.USD","BK4007","LU0889565916.HKD","LU1093756168.USD","LU0058720904.USD","LU0061475181.USD","PBE","LU0079474960.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","IE00B894F039.SGD","BK4533","IE0002141913.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2236285917.USD","LU2362540622.SGD","LU1430594728.SGD","LU0234570918.USD","BK4585","CRNX","BK4532","BK4567","IE00BZ9MQY76.HKD","IDNA","LU0417517546.SGD","LU0823416689.USD","IE00B19Z9P08.USD","LU1069344957.HKD","LU2362541273.HKD","LU2462157665.USD","IE00B19Z9Z06.USD","LU2237438978.USD","BK4588","LU2417539215.USD","IBBQ","LU0432979614.USD","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649986414","title":"每日特惠-併購","url":"https://stock-news.laohu8.com/highlight/detail?id=2649986414","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649986414?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 17:52","pubTimestamp":1783417941,"startTime":"0","endTime":"0","summary":"每日特惠-并购路透7月7日-截至周二0930 GMT，已报告以下收购要约、合并、收购和资产处置情况：** 阿布扎比国家石油公司分销业务< ADNOCDIST.AD > 表示，已同意收购壳牌< SHEL.L > 在南非的下游业务，交易隐含的企业价值约为10亿美元。这是该公司向海湾地区以外拓展业务以来迄今为止规模最大的海外收购。nL4N4381BQ** 总部位于佛罗里达州的赖特国家洪水保险公司已达成协议，将收购东京海上北美旗下公司——夏威夷第一保险公司的洪水保险保单组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4S4390SK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0878866978.SGD","LU0630314457.HKD","IDNA","LU0417517546.SGD","LU0553294199.USD","LU0072461881.USD","LU2456880835.USD","LU0788109394.HKD","LU0128525689.USD","LU1674673691.USD","IE00B2B36J28.USD","PBE","LU0158827948.USD","LU0985489474.SGD","LU0368265418.SGD","IBBQ","CRNX","LU0310799852.SGD","LU0433182093.SGD","BRO","BK4597","LU0965509010.AUD","LU1894683264.USD","LU0889565916.HKD","LU0256331488.USD","SHEL.UK","BK4533","BK4007","IE00BZ9MQY76.HKD","LU1019632923.USD","LU1934455194.USD","IE0009355771.USD","LU0575583348.USD","LU0654597011.USD","LU1430597077.USD","LU0211328371.USD","LU1430594728.SGD","LU2125154935.USD","BIB","LU0757432116.USD","LU1880398554.USD","LU2362541513.USD","VRTX","IBB","LU0979878070.USD","BBH","LU1069347547.HKD","LU2646069778.SGD","IE0002141913.USD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624600","title":"美股異動丨Crinetics盤前暴升逾99%，獲福泰製藥斥100億美元溢價超一倍收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624600","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624600?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 16:17","pubTimestamp":1783412226,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBH","LU0823416689.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU2417539215.USD","LU2456880835.USD","IE0002141913.USD","SG9999001176.USD","LU1093756325.SGD","LU0320765992.SGD","IDNA","LU1674673691.USD","IE00B19Z9P08.USD","SGXZ57979304.SGD","LU2362540622.SGD","LU2324357040.USD","LU0109394709.USD","IBB","LU1674673428.USD","LU2362541273.HKD","LU1069344957.HKD","PBE","IE00B4R5TH58.HKD","LU1093756168.USD","IE0002270589.USD","IBBQ","IE00B2B36J28.USD","BK4567","LU2236285917.USD","SG9999013999.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","LU0079474960.USD","IE00B19Z9Z06.USD","LU2362541513.USD","BK4139","BK4585","BK4588","LU0058720904.USD","BIB","LU0289739699.SGD","VRTX","IE00BZ9MQY76.HKD","LU0256863811.USD","LU1585245621.USD","BK4533","LU2237438978.USD","LU0432979614.USD","IE00B894F039.SGD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649708736","title":"100億美元砸出史上最大收購：福泰製藥(VRTX.US)溢價100%收購Crinetics(CRNX.US)，殺入內分泌賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2649708736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649708736?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 08:35","pubTimestamp":1783384535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IDNA","IE00B19Z3581.USD","LU0289739699.SGD","BK4585","LU2237438978.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU2362541273.HKD","BBH","IE00B4R5TH58.HKD","LU1585245621.USD","LU0417517546.SGD","LU0823416689.USD","LU1093756325.SGD","LU1778281490.HKD","IE00BJJMRZ35.SGD","LU2324357040.USD","LU0234570918.USD","BIB","LU2456880835.USD","IE00BZ9MQY76.HKD","LU0058720904.USD","LU2362540622.SGD","BK4139","SG9999001176.SGD","LU2417539215.USD","BK4007","IBBQ","LU1674673691.USD","LU0079474960.USD","BK4533","LU0320765992.SGD","VRTX","IE0002270589.USD","LU0256863811.USD","IBB","LU0889565916.HKD","LU1093756168.USD","LU0432979614.USD","CRNX","IE00B19Z9P08.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","PBE","BK4588","IE00B2B36J28.USD","LU1035775433.USD","SG9999001176.USD","LU1430594728.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159544198","title":"SEC文件披露：特定情況下交易終止，Crinetics Pharmaceuticals或需向福泰製藥支付3.5047億美元解約費","url":"https://stock-news.laohu8.com/highlight/detail?id=1159544198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159544198?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 05:22","pubTimestamp":1783372928,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件披露，Crinetics Pharmaceuticals Inc. 与福泰制药之间的交易若在特定情况下被终止，前者可能需要向后者支付高达3.5047亿美元的终止费用。该文件明确了触发这一巨额财务义务的具体情形。协议条款显示，这笔费用的支付并非自动生效，而是与特定的终止条件紧密挂钩。然而，这也同时意味着，一旦协议因规定情形破裂，Crinetics Pharmaceuticals将面临显著的财务支出。目前，市场正密切关注两家公司后续的动向以及该交易的具体进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","LU2362541513.USD","LU0109394709.USD","BK4533","BK4567","BK4588","VRTX","LU2324357040.USD","LU0432979614.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0058720904.USD","IBBQ","SGXZ57979304.SGD","LU0289739699.SGD","LU2417539215.USD","LU0889565916.HKD","BK4585","CRNX","IDNA","IE0002270589.USD","IE00BJT1NW94.SGD","IE00B19Z9P08.USD","LU1093756325.SGD","LU1674673428.USD","LU1674673691.USD","BK4532","LU1035775433.USD","LU1093756168.USD","SG9999013999.USD","PBE","IE00BJJMRZ35.SGD","IE00B894F039.SGD","LU1778281490.HKD","BK4007","LU0079474960.USD","LU0234570918.USD","LU2236285917.USD","LU2456880835.USD","LU1069344957.HKD","LU2362541273.HKD","LU0823416689.USD","IE00BZ9MQY76.HKD","IE00B19Z3581.USD","LU1430594728.SGD","IE00B2B36J28.USD","LU0061475181.USD","LU2237438978.USD","LU0417517546.SGD","LU0256863811.USD","IE0009355771.USD","LU2362540622.SGD","BBH","LU2462157665.USD","LU1585245621.USD","IE0002141913.USD","BIB","SG9999001176.USD","BK4139","IBB","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130028229","title":"福泰製藥百億收購案引爆市場，Crinetics盤後股價翻倍飆升，終盤收漲101%至84.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130028229","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130028229?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:17","pubTimestamp":1783369041,"startTime":"0","endTime":"0","summary":"在福泰制药宣布一项价值高达100亿美元的收购协议后，Crinetics Pharmaceuticals Inc.的股价在盘后交易时段应声暴涨，涨幅超过一倍。截至最新数据，该公司股价飙升101%，报收于每股84.80美元。福泰制药的巨额收购计划，不仅彰显了其在相关治疗领域的战略雄心，也直接将收购标的Crinetics推向了资本市场的聚光灯下。对于Crinetics而言，这笔交易意味着其研发价值获得了市场顶尖参与者的高度认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","IE00BFTCPJ56.SGD","IBB","LU0079474960.USD","LU1069344957.HKD","LU1585245621.USD","LU1093756168.USD","LU0234570918.USD","IE00B894F039.SGD","LU1093756325.SGD","LU2236285917.USD","LU0289739699.SGD","LU1430594728.SGD","BK4588","LU1778281490.HKD","SG9999001176.SGD","LU2417539215.USD","IE0002141913.USD","BK4585","BK4533","BK4532","BK4139","BBH","LU0061475181.USD","LU0417517546.SGD","IE00B19Z9P08.USD","IDNA","IE00BJT1NW94.SGD","BIB","LU0432979614.USD","LU2237438978.USD","LU0823416689.USD","LU0058720904.USD","LU0109394709.USD","LU2362541513.USD","CRNX","IBBQ","LU2362541273.HKD","LU2362540622.SGD","LU0256863811.USD","PBE","LU1674673691.USD","IE00B4R5TH58.HKD","IE0002270589.USD","IE00B19Z3581.USD","LU0889565916.HKD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","SG9999013999.USD","IE0009355771.USD","LU1035775433.USD","LU1674673428.USD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","BK4007","LU2456880835.USD","SGXZ57979304.SGD","VRTX","LU2462157665.USD","LU2324357040.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679149","title":"生物製藥公司Crinetics盤後升逾100%福泰製藥將以85美元/股收購公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679149?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:09","pubTimestamp":1783368555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2456880835.USD","LU1093756168.USD","IBBQ","LU2462157665.USD","LU2236285917.USD","IE00B19Z3581.USD","IDNA","BK4532","LU2324357040.USD","IE00B19Z9P08.USD","BK4533","LU1035775433.USD","MRNX","LU0289739699.SGD","LU1778281490.HKD","IBB","LU0823416689.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","BBP","BIB","SG9999001176.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","VRTX","LU0061475181.USD","BK4139","LU1585245621.USD","LU2362540622.SGD","LU2362541513.USD","LU1674673691.USD","LU2237438978.USD","SGXZ57979304.SGD","LU0320765992.SGD","BK4585","LU2417539215.USD","PBE","LU1674673428.USD","SG9999013999.USD","LU0079474960.USD","UUP","BK4588","IE00BJJMRZ35.SGD","LU2362541273.HKD","MRNY","IE0002141913.USD","BBH","UDN","IE00B19Z9Z06.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679469","title":"Vertex將以100億美元收購Crinetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679469","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679469?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:08","pubTimestamp":1783368527,"startTime":"0","endTime":"0","summary":"Vertex将以100亿美元收购Crinetics路透7月6日-Vertex Pharmaceuticals（VRTX.O）将以约100亿美元的总股权价值收购Crinetics Pharmaceuticals（CRNX.O），两家公司周一宣布了这一消息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4S4381BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU1674673428.USD","IE00B2B36J28.USD","LU2362540622.SGD","LU0058720904.USD","BK4567","IE00B894F039.SGD","LU2237438978.USD","IE00B19Z3581.USD","LU2417539215.USD","LU0289739699.SGD","LU2456880835.USD","IBB","SG9999013999.USD","BK4139","IE00B19Z3B42.SGD","LU0320765992.SGD","IDNA","LU1778281490.HKD","IBBQ","BK4585","LU1674673691.USD","LU2236285917.USD","BK4588","LU0079474960.USD","BK4532","LU0061475181.USD","LU0432979614.USD","LU0109394709.USD","IE00BZ9MQY76.HKD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU0823416689.USD","PBE","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","VRTX","IE00B19Z9P08.USD","LU1035775433.USD","BIB","LU1069344957.HKD","LU2324357040.USD","BBH","IE0002270589.USD","LU1585245621.USD","SG9999001176.SGD","CRNX","LU0256863811.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics與福泰製藥交易預計2029年提升後者非GAAP運營收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127833937?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测，Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作，预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应，增强福泰制药的盈利质量。分析指出，该合作不仅将拓展福泰制药在特定治疗领域的产品管线，还可能优化其整体运营效率。市场预期，随着合作项目进入成熟阶段，其对财务指标的正面影响将逐步显现。\n财务模型显示，此次合作带来的收入增长与成本协同效应，是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程，以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","SG9999013999.USD","BBH","IE00BFTCPJ56.SGD","LU0058720904.USD","IDNA","LU0889565916.HKD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU0823416689.USD","LU2362540622.SGD","BK4007","LU0109394709.USD","SG9999001176.SGD","LU2362541513.USD","IE00BJJMRZ35.SGD","PBE","LU0234570918.USD","LU1674673428.USD","IE00BZ9MQY76.HKD","LU1430594728.SGD","IE0002141913.USD","LU2236285917.USD","IE0009355771.USD","IBBQ","IE00B4R5TH58.HKD","LU1035775433.USD","IE00B894F039.SGD","LU1674673691.USD","LU1778281490.HKD","LU2462157665.USD","IE00B19Z3581.USD","LU0256863811.USD","LU2417539215.USD","IE00B19Z9Z06.USD","IE0002270589.USD","LU1069344957.HKD","BK4532","IBB","CRNX","IE00B19Z9P08.USD","BK4588","LU2456880835.USD","IE00B2B36J28.USD","BIB","LU0320765992.SGD","LU2324357040.USD","LU1093756168.USD","LU0289739699.SGD","LU2362541273.HKD","BK4585","BK4533","SGXZ57979304.SGD","VRTX","LU2237438978.USD","BK4139","LU1093756325.SGD","LU0432979614.USD","BK4567","SG9999001176.USD","LU0417517546.SGD","LU0061475181.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals：融資獲美國銀行與摩根士丹利的45億美元全額承諾過橋貸款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179291339?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划，已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE0002141913.USD","IE00B19Z3581.USD","BIB","IE00B19Z3B42.SGD","LU0432979614.USD","IDNA","LU2362541513.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","VRTX","LU1035775433.USD","LU0256863811.USD","LU1585245621.USD","LU2456880835.USD","IE0009355771.USD","IE00B19Z9P08.USD","LU2462157665.USD","LU2324357040.USD","SG9999001176.USD","LU0823416689.USD","LU1093756168.USD","BK4533","LU0320765992.SGD","LU2417539215.USD","PBE","LU1069344957.HKD","LU2362540622.SGD","LU0079474960.USD","IE00B4R5TH58.HKD","LU0417517546.SGD","IE00B2B36J28.USD","LU1430594728.SGD","LU0889565916.HKD","IE00B19Z9Z06.USD","LU1674673691.USD","LU1674673428.USD","BK4532","BK4139","IE0002270589.USD","LU1093756325.SGD","LU1778281490.HKD","LU2237438978.USD","SG9999013999.USD","BK4567","IE00B894F039.SGD","LU0234570918.USD","IE00BZ9MQY76.HKD","IBBQ","CRNX","SG9999001176.SGD","LU0061475181.USD","BBH","BK4585","LU0289739699.SGD","LU2236285917.USD","SGXZ57979304.SGD","LU2362541273.HKD","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4588","LU0058720904.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154393441","title":"福泰製藥就囊性纖維化療法Alyftrek與泛加拿大藥品聯盟簽署意向書","url":"https://stock-news.laohu8.com/highlight/detail?id=1154393441","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154393441?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 22:25","pubTimestamp":1783347947,"startTime":"0","endTime":"0","summary":"福泰制药与泛加拿大药品联盟就囊性纤维化治疗药物Alyftrek的潜在合作签署了意向书。此举标志着该药物在加拿大市场准入进程中的一个重要步骤，旨在为患者提供新的治疗选择。意向书的签署为后续正式协议的谈判奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","IBB","LU2237438978.USD","IE00BZ9MQY76.HKD","LU0058720904.USD","BK4567","LU0234570918.USD","IE00B19Z3581.USD","IE00B894F039.SGD","LU1585245621.USD","LU2362541273.HKD","SG9999001176.SGD","LU2362540622.SGD","VRTX","LU2417539215.USD","LU2462157665.USD","BK4533","BBH","LU0256863811.USD","SG9999013999.USD","LU1069344957.HKD","LU0109394709.USD","LU1674673428.USD","IBBQ","IE00B4R5TH58.HKD","BK4139","LU2324357040.USD","SG9999001176.USD","BK4532","IE00B19Z9Z06.USD","LU0289739699.SGD","LU1778281490.HKD","BIB","LU1035775433.USD","LU2236285917.USD","LU2456880835.USD","IE0002270589.USD","LU1430594728.SGD","PBE","IE00BFTCPJ56.SGD","LU2362541513.USD","BK4585","LU1093756168.USD","BK4588","LU0079474960.USD","LU0823416689.USD","LU0417517546.SGD","SGXZ57979304.SGD","LU0061475181.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","IDNA","IE0002141913.USD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","IE0009355771.USD","LU1093756325.SGD","IE00B19Z9P08.USD","LU1674673691.USD","LU0320765992.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":8,"totalSize":152,"code":"91000000","status":"200"}]}}